Nonsurgical electrical ablation of tachycardias: importance of prior in vitro testing of catheter leads.
Nonsurgical electrical ablation of tachycardia pathways or foci has been attempted or carried out using a variety of temporary pacing catheter leads. To determine the ability of such leads to withstand the high energies used in such procedures, 34 leads were suspended in saline, and subjected to repeated electrical shocks. Small (4 French) temporary pacing leads made by a variety of manufacturers tolerated multiple shocks up to 100 joules; above this level, failures became increasingly common, although usually the failure mode was benign with respect to patient care implications. Testing of 6, 7, and 8 French leads revealed considerable inter-and intra-manufacturer differences in the ability to withstand higher energy shocks, reflecting differences in materials and fabrication techniques. It is concluded that careful in vitro lead testing is required prior to using identical models in humans for arrhythmia ablation procedures.
D006328:Cardiac Catheterization / Q000295:instrumentation; D004599:Electric Stimulation Therapy / Q000295:instrumentation*; D004868:Equipment Failure; D006801:Humans; D013610:Tachycardia / Q000628:therapy*